Pacific Biosciences's total assets for Q2 2025 were $825.47M, a decrease of -4.10% from the previous quarter. PACB total liabilities were $763.98M for the fiscal quarter, a -0.67% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.